Logo image of IKT

INHIBIKASE THERAPEUTICS INC (IKT) Stock Analyst Ratings

USA - NASDAQ:IKT - US45719W2052 - Common Stock

1.49 USD
-0.04 (-2.61%)
Last: 11/21/2025, 8:00:02 PM
1.5 USD
+0.01 (+0.67%)
After Hours: 11/21/2025, 8:00:02 PM
Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to IKT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 8.16. This target is 447.65% above the current price.
IKT was analyzed by 7 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about IKT.
In the previous month the buy percentage consensus was at a similar level.
IKT was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

IKT Historical Analyst RatingsIKT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -54 -49 -44 -39 -34 -29 -24 -19 -14 -9 -4 2 4 6

Price Target & Forecast

Price Low Median Mean High 1.498.088.168.168.40 - 442.28% 447.65% 447.65% 463.76%

Related screens

IKT Current Analyst RatingIKT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2025-03-28 HC Wainwright & Co. Reiterate Neutral -> Neutral
2025-02-12 HC Wainwright & Co. Downgrade Buy -> Neutral
2024-11-08 Jefferies Initiate Buy
2024-10-14 HC Wainwright & Co. Maintains Buy -> Buy
2024-08-16 HC Wainwright & Co. Maintains Buy -> Buy
2024-05-21 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-07 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-05 HC Wainwright & Co. Maintains Buy -> Buy
2023-08-15 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-30 HC Wainwright & Co. Maintains Buy -> Buy
2023-06-22 HC Wainwright & Co. Reiterate Buy -> Buy
2023-04-18 HC Wainwright & Co. Initiate Buy
2022-11-16 JonesTrading Downgrade Buy -> Hold
2021-07-15 JonesTrading Initiate Buy

INHIBIKASE THERAPEUTICS INC / IKT FAQ

What is the price target for IKT stock?

7 analysts have analysed IKT and the average price target is 8.16 USD. This implies a price increase of 447.65% is expected in the next year compared to the current price of 1.49.


Can you provide the consensus rating for INHIBIKASE THERAPEUTICS INC stock?

The consensus rating for INHIBIKASE THERAPEUTICS INC (IKT) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.